Cargando…
Bridging the gap: aligning economic research with disease burden
INTRODUCTION: Cost-effectiveness analysis (CEA) is critical for identifying high-value interventions that address significant unmet need. This study examines whether CEA study volume is proportionate to the burden associated with 21 major disease categories. METHODS: We searched the Tufts Medical Ce...
Autores principales: | Do, Lauren A, Synnott, Patricia G, Ma, Siyu, Ollendorf, Daniel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186754/ https://www.ncbi.nlm.nih.gov/pubmed/34099483 http://dx.doi.org/10.1136/bmjgh-2021-005673 |
Ejemplares similares
-
The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
por: Synnott, Patricia G., et al.
Publicado: (2020) -
The impact of external reference pricing on pharmaceutical costs and market dynamics
por: Voehler, Dominic, et al.
Publicado: (2023) -
Bridging the gaps in statistical models of protein alignment
por: Sumanaweera, Dinithi, et al.
Publicado: (2022) -
Bridging the genomic data gap in Africa: implications for global disease burdens
por: Omotoso, Olabode Ebenezer, et al.
Publicado: (2022) -
CODEX-aligned dietary fiber definitions help to bridge the ‘fiber gap’
por: Jones, Julie Miller
Publicado: (2014)